openPR Logo
Press release

Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific

04-14-2026 08:16 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Cardiac Monitoring Devices Market Insights

Cardiac Monitoring Devices Market Insights

The leading companies operating in the cardiac monitoring devices market include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE Healthcare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., Osypka Medical, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Mindray, Dragerwerk AG & CO. KGaA, Lepu Medical Technologies, Fukuda Denshi Co., Ltd., and others.
The global cardiac monitoring devices market is poised for robust, sustained expansion, driven by the rising burden of cardiovascular diseases, surging demand for remote patient monitoring, and accelerating adoption of AI-enabled and wearable monitoring technologies across key geographies.

Key Takeaways

*
The global cardiac monitoring devices market is projected to grow from USD 22,319.66 million in 2025 to USD 34,948.16 million by 2034, reflecting a CAGR of 5.17% during the forecast period from 2026 to 2034.

*
North America is expected to dominate the cardiac monitoring devices market, primarily driven by the increasing prevalence of cardiovascular diseases and associated risk factors such as hypertension, obesity, and diabetes, alongside the growing demand for remote patient monitoring solutions supported by the rising adoption of telehealth and home-based care.

*
The cardiac monitoring devices market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs) such as heart failure, arrhythmias, and coronary artery disease, along with rising risk factors including hypertension, diabetes, obesity, and sedentary lifestyles.

*
Technological trends include the integration of artificial intelligence, cloud connectivity, miniaturized wearable devices, and improved battery life, which are enhancing device accuracy, convenience, and clinical outcomes, thereby supporting overall market expansion.

*
By product type, demand is rising for ECG devices including Holter monitors, resting ECG, and stress ECG, as well as implantable loop recorders, event recorders, echocardiogram systems, and mobile cardiac telemetry solutions across hospital, ambulatory, and homecare settings.

*
In the product type segment, within the ECG devices segment, the Holter monitors category is estimated to account for the largest market share in 2025.

*
Key companies operating in the cardiac monitoring devices market include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE Healthcare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., Osypka Medical, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Mindray, Dragerwerk AG & CO. KGaA, Lepu Medical Technologies, Fukuda Denshi Co., Ltd., and others.

*
Recent developments are focused on AI-driven cardiac rhythm interpretation, real-time wireless data transmission, expanded wearable device portfolios, and seamless integration with hospital EMR and telehealth platforms to support proactive cardiovascular care.

For more recent advancements in this landscape, visit Cardiac Monitoring Devices Market Recent Developments [https://www.delveinsight.com/sample-request/cardiac-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Cardiac Monitoring Devices Market Overview and Growth Outlook

The cardiac monitoring devices market is forecast to expand from USD 22,319.66 million in 2025 to USD 34,948.16 million by 2034, growing at a CAGR of 5.17% from 2026 to 2034. This trajectory reflects a deepening clinical focus on continuous cardiovascular surveillance, a secular rise in lifestyle-related heart conditions, and sustained investment in cardiac care infrastructure across both developed and emerging markets.

Dive deeper into the Cardiac Monitoring Devices market trends @ Cardiac Monitoring Devices Market Insights and Analysis [https://www.delveinsight.com/sample-request/cardiac-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Cardiac Monitoring Devices Market Regional Insights

North America is expected to dominate the cardiac monitoring devices market, reinforced by the high incidence of cardiovascular diseases, a growing geriatric population, and the early adoption of advanced technologies, including AI-enabled wearables and remote patient monitoring systems. The region benefits from a well-established healthcare infrastructure, favorable reimbursement policies, and consistent FDA approvals for innovative cardiac devices, all of which strengthen its market dominance.

Furthermore, Europe is contributing significantly to the expansion of the cardiac monitoring devices market, supported by the increasing prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and favorable regulatory and reimbursement policies, while Asia-Pacific and other regions also show rising adoption of technologically advanced monitoring solutions.

For in-depth regional analysis, visit Cardiac Monitoring Devices Market Regional Analysis and Market Share [https://www.delveinsight.com/sample-request/cardiac-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Cardiac Monitoring Devices Market Segmentation

*
By Product Type: ECG Devices (Holter Monitors; Resting ECG; Stress ECG), Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, Others

*
By End-User: Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others

*
By Geography: North America, Europe, Asia-Pacific, Rest of the World

Cardiac Monitoring Devices Market Competitive Landscape

The leading companies operating in the cardiac monitoring devices market include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE Healthcare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., Osypka Medical, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Mindray, Dragerwerk AG & CO. KGaA, Lepu Medical Technologies, Fukuda Denshi Co., Ltd., and others.

Which company is expected to dominate the Cardiac Monitoring Devices market? Know @ Cardiac Monitoring Devices Competitive Landscape [https://www.delveinsight.com/sample-request/cardiac-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Key Features of DelveInsight's Cardiac Monitoring Devices Market Report

*
Detailed market sizing and forecasts from 2025 to 2034 at global and regional levels, including revenue projections and CAGR analysis.

*
Granular assessment of market contribution by major regions such as North America, Europe, Asia-Pacific, and other high-growth markets.

*
Coverage of key product categories, including ECG devices (Holter monitors, resting ECG, stress ECG), implantable loop recorders, event recorders, echocardiogram systems, and mobile cardiac telemetry solutions.

*
Evaluation of usage across care settings, including hospitals, ambulatory surgical centers, and homecare environments where cardiac monitoring is routinely performed.

*
Detailed discussion on why North America is expected to dominate, including drivers such as high CVD prevalence, technological adoption, reimbursement support, and a strong pipeline of FDA approvals.

*
Insight into Europe's growth drivers, including public healthcare infrastructure, prenatal care standards, and an increasing emphasis on early cardiovascular complication detection.

*
Systematic coverage of demand drivers such as aging populations, sedentary lifestyles, rising obesity and diabetes rates, and the growing shift toward preventive and value-based cardiovascular care.

*
Identification of evolving opportunities around AI-enabled rhythm interpretation, wireless and wearable monitoring, remote connectivity, and integration with hospital information and telehealth systems.

*
Profiles and strategic analysis of major companies in the cardiac monitoring devices landscape.

*
Assessment of market concentration, technology adoption trends, and strategic levers for market entry or expansion.

Request Custom Analysis or Speak to Our Analyst @ Cardiac Monitoring Devices Market Report [https://www.delveinsight.com/sample-request/cardiac-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cardiac-monitoring-devices-market-set-for-sustained-growth-at-517-cagr-through-2034-delveinsight-philips-medtronic-and-boston-scientific]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific here

News-ID: 4471004 • Views:

More Releases from ABNewswire

Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Driving Innovation in the Therapeutics | DelveInsight
Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Drivin …
DelveInsight's "Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight
Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contr …
DelveInsight's "Diabetic Macular Edema Pipeline Insight 2026" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Compan …
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insights 2026" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diffuse Large B-Cell Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Diffuse Large B-Cell
HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Co …
DelveInsight's "HER2-Negative Breast Cancer Pipeline Insight 2026" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2-Negative Breast Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download DelveInsight's comprehensive

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,